COPD

The Game-Changer in COPD: What the Latest FDA Approval Means for Breathless Millions

The Game-Changer in COPD: What the Latest FDA Approval Means for Breathless Millions

The Game-Changer in COPD: What the Latest FDA Approval Means for Breathless Millions

Warren Gilbert 26 May 2025

The FDA has approved mepolizumab as an add-on therapy for adults with COPD, offering new hope to...

This Fresh FDA Decision Could Transform Life for Millions With COPD

This Fresh FDA Decision Could Transform Life for Millions With COPD

This Fresh FDA Decision Could Transform Life for Millions With COPD

Zara Quiff 26 May 2025

COPD affects over 16 million Americans, often causing life-limiting breathlessness and frequent exacerbations. Mepolizumab, a monoclonal antibody...

This New Treatment Signals a Turning Point for Millions With COPD—Here’s Why Experts Are Buzzing

This New Treatment Signals a Turning Point for Millions With COPD—Here’s Why Experts Are Buzzing

This New Treatment Signals a Turning Point for Millions With COPD—Here’s Why Experts Are Buzzing

Quinn Huxley 26 May 2025

The FDA has approved mepolizumab, an innovative biologic therapy, as an add-on for chronic obstructive pulmonary disease...